A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity

International Journal of Medical Microbiology

Volumn 297, Issue 6, 2007, Pages 471-478

  Lintges, Maria ^a   Arlt, Sabine ^a   Uciechowski, Peter ^a   Plümäkers, Birgit ^a   Reinert, Ralf R ^a   Al Lahham, Adnan ^b   Lütticken, Rudolf ^a   Rink, Lothar ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b GERMAN JORDANIAN UNIVERSITY   (Jordan)

Author keywords

Multiplex PCR; Streptococcus; Superantigens; T cell proliferation; Toxin genes

Indexed keywords

BACTERIAL TOXIN; SUPERANTIGEN;

ANTIGEN DETECTION; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; NECROTIZING FASCIITIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SMEZ GENE; SPEC GENE; SPEG GENE; SPEH GENE; SPEI GENE; SPEJ GENE; SPEK GENE; SPEL GENE; SPEM GENE; SSA GENE; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

EID: 34548500372     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2007.03.015     Document Type: Article

References (52)

1. Abdulmawjood A., and Lammler C. Amplification of 16S ribosomal RNA gene sequences for the identification of streptococci of Lancefield group B. Res. Vet. Sci. 67 (1999) 159-162
2. Alouf J.E., and Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int. J. Med. Microbiol. 292 (2003) 429-440
3. Baker M.D., and Acharya K.R. Superantigens: structure-function relationships. Int. J. Med. Microbiol. 293 (2004) 529-537
4. Baker M., Gutman D.M., Papageorgiou A.C., Collins C.M., and Acharya K.R. Structural features of a zinc binding site in the superantigen streptococcal pyrogenic exotoxin A (SpeA1): implications for MHC class II recognition. Protein Sci. 10 (2001) 1268-1273
5. Banks M.C., Kamel N.S., Zabriskie J.B., Larone D.H., Ursea D., and Posnett D.N. Staphylococcus aureus express unique superantigens depending on the tissue source. J. Infect. Dis. 187 (2003) 77-86
6. Beres S.B., Sylva G.L., Barbian K.D., Lei B., Hoff J.S., Mammarella N.D., Liu M.Y., Smoot J.C., Porcella S.F., Parkins L.D., Campbell D.S., Smith T.M., McCormick J.K., Leung D.Y., Schlievert P.M., and Musser J.M. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 99 (2002) 10078-10083
7. Bessen D.E., Izzo M.W., Fiorentino T.R., Caringal R.M., Hollingshead S.K., and Beall B. Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J. Infect. Dis. 179 (1999) 627-636
8. Bisno A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325 (1991) 783-793
9. Bisno A.L., Brito M.O., and Collins C.M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3 (2003) 191-200
10. Bos J.D., and de Rie M.A. The pathogenesis of psoriasis: immunological facts and speculations. Immunol. Today 20 (1999) 40-46
11. Carapetis J.R., Steer A.C., Mulholland E.K., and Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5 (2005) 685-694
12. Cole B.C., Kartchner D.R., and Wells D.J. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM. J. Immunol. 144 (1990) 425-431
13. Ekelund K., Skinhoj P., Madsen J., and Konradsen H.B. Reemergence of emm1 and a changed superantigen profile for group A streptococci causing invasive infections: results from a nationwide study. J. Clin. Microbiol. 43 (2005) 1789-1796
14. Eriksson A., Eriksson B., Holm S.E., and Norgren M. Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains. Clin. Diagn. Lab. Immunol. 6 (1999) 133-136
15. Farrell D.J., Morrissey I., Bakker S., and Felmingham D. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J. Antimicrob. Chemother. 48 (2001) 541-544
16. Fast D.J., Schlievert P.M., and Nelson R.D. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor. J. Immunol. 140 (1988) 949-953
17. Ferretti J.J., McShan W.M., Ajdic D., Savic D.J., Savic G., Lyon K., Primeaux C., Sezate S., Suvorov A.N., Kenton S., Lai H.S., Lin S.P., Qian Y., Jia H.G., Najar F.Z., Ren Q., Zhu H., Song L., White J., Yuan X., Clifton S.W., Roe B.A., and McLaughlin R. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 98 (2001) 4658-4663
18. Fraser J., Arcus V., Kong P., Baker E., and Proft T. Superantigens - powerful modifiers of the immune system. Mol. Med. Today 6 (2000) 125-132
19. Gupta-Malhotra M., Viteri-Jackson A., Thomas W., and Zabriskie J.B. Antibodies to highly conserved peptide sequence of staphylococcal and streptococcal superantigens in Kawasaki disease. Exp. Mol. Pathol. 76 (2004) 117-121
20. Herman A., Labrecque N., Thibodeau J., Marrack P., Kappler J.W., and Sekaly R.P. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc. Natl. Acad. Sci. USA 88 (1991) 9954-9958
21. Igwe E.I., Shewmaker P.L., Facklam R.R., Farley M.M., van Beneden C., and Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol. Lett. 229 (2003) 259-264
22. Johnson L.P., Tomai M.A., and Schlievert P.M. Bacteriophage involvement in group A streptococcal pyrogenic exotoxin A production. J. Bacteriol. 166 (1986) 623-627
23. Kamezawa Y., Nakahara T., Nakano S., Abe Y., Nozaki-Renard J., and Isono T. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect. Immun. 65 (1997) 3828-3833
24. Kotzin B.L., Leung D.Y., Kappler J., and Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 54 (1993) 99-166
25. Lau S.K.P., Woo P.C.Y., Yim T.-C., To A.P.C., and Yuen K.-Y. Molecular characterization of a strain of group A Streptococcus isolated from a patient with a psoas abscess. J. Clin. Microbiol. 41 (2003) 4888-4891
26. Levy R.M., Leyden J.J., and Margolis D.J. Colonisation rates of Streptococcus pyogenes and Staphylococcus aureus in the oropharynx of a young adult population. Clin. Microbiol. Infect. 11 (2005) 153-155
27. Llewelyn M., and Cohen J. Superantigen antagonist peptides. Crit. Care 5 (2001) 53-55
28. Llewelyn M., and Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect. Dis. 2 (2002) 156-162
29. McCormick J.K., Pragman A.A., Stolpa J.C., Leung D.Y., and Schlievert P.M. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect. Immun. 69 (2001) 1381-1388
30. Mehrotra M., Wang G., and Johnson W.M. Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance. J. Clin. Microbiol. 38 (2000) 1032-1035
31. Miyoshi-Akiyama T., Zhao J., Kato H., Kikuchi K., Totsuka K., Kataoka Y., Katsumi M., and Uchiyama T. Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol. Microbiol. 47 (2003) 1589-1599
32. Monday S.R., and Bohach G.A. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37 (1999) 3411-3414
33. Muldrew K.L., Simpson J.F., Stratton C.W., and Tang Y.-W. Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen detection. J. Mol. Diagn. 7 (2005) 641-645
34. Nelson K., Schlievert P.M., Selander R.K., and Musser J.M. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J. Exp. Med. 174 (1991) 1271-1274
35. Norrby-Teglund A., Holm S.E., and Norgren M. Detection and nucleotide sequence analysis of the speC gene in Swedish clinical group A streptococcal isolates. J. Clin. Microbiol. 32 (1994) 705-709
36. Paliard X., West S.G., Lafferty J.A., Clements J.R., Kappler J.W., Marrack P., and Kotzin B.L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253 (1991) 325-329
37. Papageorgiou A.C., and Acharya K.R. Microbial superantigens: from structure to function. Trends Microbiol. 8 (2000) 369-375
38. Petersson K., Forsberg G., and Walse B. Interplay between superantigens and immunoreceptors. Scand. J. Immunol. 59 (2004) 345-355
39. Podbielski A., Melzer B., and Lütticken R. Application of the polymerase chain reaction to study the M protein (-like) gene family in beta-hemolytic streptococci. Med. Microbiol. Immunol. 180 (1991) 213-227
40. Proft T., and Fraser J.D. Bacterial superantigens. Clin. Exp. Immunol. 133 (2003) 299-306
41. Proft T., Moffatt S.L., Berkahn C.J., and Fraser J.D. Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 189 (1999) 89-102
42. Proft T., Moffatt S.L., Weller K.D., Paterson A., Martin D., and Fraser J.D. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation. J. Exp. Med. 191 (2000) 1765-1776
43. Proft T., Arcus V.L., Handley V., Baker E.N., and Fraser J.D. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J. Immunol. 166 (2001) 6711-6719
44. Proft T., Webb P.D., Handley V., and Fraser J.D. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 71 (2003) 1361-1369
45. Proft T., Webb P.D., Handley V., and Fraser J.D. Identification & characterisation of the two novel streptococcal pyrogenic exotoxins SPE-L & SPE-M. Indian J. Med. Res. 119 (2004) 37-43
46. Rink L., and Kirchner H. Mycoplasma arthritidis - derived superantigen. Chem. Immunol. 55 (1992) 137-145
47. Rink L., Luhm J., Koester M., and Kirchner H. Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation. J. Interferon Cytokine Res. 16 (1996) 41-47
48. Schmitz F.J., Beyer A., Charpentier E., Normark B.H., Schade M., Fluit A.C., Hafner D., and Novak R. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J. Infect. Dis. 188 (2003) 1578-1586
49. Smoot L.M., McCormick J.K., Smoot J.C., Hoe N.P., Strickland I., Cole R.L., Barbian K.D., Earhart C.A., Ohlendorf D.H., Veasy L.G., Hill H.R., Leung D.Y., Schlievert P.M., and Musser J.M. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect. Immun. 70 (2002) 7095-7104
50. Tamura F., Nakagawa R., Akuta T., Okamoto S., Hamada S., Maeda H., Kawabata S., and Akaike T. Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B). Infect. Immun. 72 (2004) 4836-4847
51. Uchiyama T., Miyoshi-Akiyama T., Kato H., Fujimaki W., Imanishi K., and Yan X.J. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 151 (1993) 4407-4413
52. Wicks I., McColl G., and Harrison L. New perspectives on rheumatoid arthritis. Immunol. Today 15 (1994) 553-556